Literature DB >> 559691

Salicylate metabolism in twins. Evidence suggesting a genetic influence and induction of salicylurate formation.

D E Furst, N Gupta, H E Paulus.   

Abstract

To evaluate the contribution of genetic influences on the individual variation in plateau serum salicylate levels, salicylate metabolism was studied in seven pairs of identical and six pairs of fraternal twins.Under the conditions of this study, after a single i.v. dose (40 mg/kg) of sodium salicylate, the serum salicylate concentration versus time curve approximated a straight line on linear coordinates (appeared approximately zero order). The slopes of the decay curves ranged between 0.64 and 1.02. The intrapair variation for identical twin pairs was significantly less than for fraternal twin pairs (P = 0.044). Likewise pleateau serum salicylic acid concentrations (milligrams/deciliter) and total salicylic acid excretion rate after multiple doses demonstrated significantly less intrapair variation for identical twins than for fraternal twins (P = 0.043 and 0.006). Plateau salicylurate excretion (milligram/kilogram per hour) differences after multiple dosing had a P = 0.067. Michaelis-Menton constant for salicylurate formation and hours to 50% excretion after the i.v. dose were not different when comparing identical and nonidentical twins. Salicylurate formation rates were increased after 3 days of oral therapy, and this induction phenomenon may account for much of the apparent discrepancy between genetic influences on salicylurate formation rates observed after single and multiple dose salicylate administration. This study suggests that the plateau concentration of serum salicylate varies among individuals given the same weight-adjusted dose in part because of genetically determined variations in their metabolism of salicylate.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 559691      PMCID: PMC372340          DOI: 10.1172/JCI108766

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  VARIATION IN RATE OF SALICYLATE ELIMINATION BY HUMANS.

Authors:  G LEVY; L E HOLLISTER
Journal:  Br Med J       Date:  1964-08-01

2.  GASTROINTESTINAL ABSORPTION OF ASPIRIN ANHYDRIDE.

Authors:  G LEVY; B A GAGLIARDI
Journal:  J Pharm Sci       Date:  1963-08       Impact factor: 3.534

3.  A COMPARISON OF ESTIMATES OF MICHAELIS-MENTEN KINETIC CONSTANTS FROM VARIOUS LINEAR TRANSFORMATIONS.

Authors:  J E DOWD; D S RIGGS
Journal:  J Biol Chem       Date:  1965-02       Impact factor: 5.157

4.  A KINETIC STUDY OF THE ELIMINATION OF SALICYLATE IN MAN.

Authors:  C BEDFORD; A J CUMMINGS; B K MARTIN
Journal:  Br J Pharmacol Chemother       Date:  1965-04

5.  Pharmacogenetics.

Authors:  D A EVANS; C A CLARKE
Journal:  Br Med Bull       Date:  1961-09       Impact factor: 4.291

6.  The interpretation of twin data.

Authors:  O KEMPTHORNE; R H OSBORNE
Journal:  Am J Hum Genet       Date:  1961-09       Impact factor: 11.025

7.  Pharmacological implications of microsomal enzyme induction.

Authors:  A H Conney
Journal:  Pharmacol Rev       Date:  1967-09       Impact factor: 25.468

8.  Genetic control of dicumarol levels in man.

Authors:  E S Vesell; J G Page
Journal:  J Clin Invest       Date:  1968-12       Impact factor: 14.808

9.  Genetic and environmental factors affecting ethanol metabolism in man.

Authors:  E S Vesell; J G Page; G T Passananti
Journal:  Clin Pharmacol Ther       Date:  1971 Mar-Apr       Impact factor: 6.875

10.  Capacity-limited salicylurate formation during prolonged administration of aspirin to healthy human subjects.

Authors:  G Levy; A W Vogel; L P Amsel
Journal:  J Pharm Sci       Date:  1969-04       Impact factor: 3.534

View more
  14 in total

Review 1.  Nonlinear pharmacokinetics: clinical Implications.

Authors:  T M Ludden
Journal:  Clin Pharmacokinet       Date:  1991-06       Impact factor: 6.447

Review 2.  Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid.

Authors:  J O Miners
Journal:  Clin Pharmacokinet       Date:  1989-11       Impact factor: 6.447

Review 3.  Adverse reactions and interactions with aspirin. Considerations in the treatment of the elderly patient.

Authors:  J Karsh
Journal:  Drug Saf       Date:  1990 Sep-Oct       Impact factor: 5.606

Review 4.  Assessment of methods to identify sources of interindividual pharmacokinetic variations.

Authors:  E S Vesell; M B Penno
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

5.  Monogenic control of variations in antipyrine metabolite formation. New polymorphism of hepatic drug oxidation.

Authors:  M B Penno; E S Vesell
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

6.  Metabolism of salicylate during chronic aspirin therapy.

Authors:  R H Rumble; P M Brooks; M S Roberts
Journal:  Br J Clin Pharmacol       Date:  1980-01       Impact factor: 4.335

7.  Model representation of salicylate pharmacokinetics using unbound plasma salicylate concentrations and metabolite urinary excretion rates following a single oral dose.

Authors:  J Shen; S Wanwimolruk; R D Purves; E G McQueen; M S Roberts
Journal:  J Pharmacokinet Biopharm       Date:  1991-10

8.  Induction of salicyluric acid formation in rheumatoid arthritis patients treated with salicylates.

Authors:  R O Day; D D Shen; D L Azarnoff
Journal:  Clin Pharmacokinet       Date:  1983 May-Jun       Impact factor: 6.447

9.  Monitoring plasma concentrations of salicylate.

Authors:  M Mandelli; G Tognoni
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

10.  Interaction of salicylate and corticosteroids in man.

Authors:  R O Day; G Harris; M Brown; G G Graham; G D Champion
Journal:  Br J Clin Pharmacol       Date:  1988-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.